sertraline overdose medical management
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative emergency medicine and toxicology sources. Here is the synthesized management guide:
Sertraline Overdose: Medical Management
Overview
Sertraline is an SSRI — one of the safest drug classes in overdose. Ingestions of up to 30× the daily dose are associated with few or no symptoms, and fatalities from pure SSRI overdose are extremely uncommon. — Rosen's Emergency Medicine, p. 2925
Clinical Features
| Severity | Manifestations |
|---|---|
| Mild (most cases) | GI upset (nausea, vomiting), mild CNS depression, "shakiness" |
| Moderate | Mild tachycardia, somnolence, vomiting |
| Severe (rare) | Seizures (~2%), dysrhythmias, serotonin syndrome |
Citalopram/escitalopram note: These agents carry a higher risk of QTc prolongation and seizures than sertraline specifically — relevant when identifying the co-ingestant. Sertraline in pure overdose has minimal cardiac effects.
Initial Workup
- ECG: Assess QTc (and QRS in suspected poly-drug ingestion). Usually unremarkable or shows sinus tachycardia after sertraline alone.
- Labs: Electrolytes (K⁺, Mg²⁺), renal function; screen for rhabdomyolysis (CK, urine myoglobin) if significant neuromuscular activity is present.
- Serum SSRI levels: Not performed by most labs and do not guide management.
- Urine drug screen: Standard screens do not detect SSRIs.
- History: Confirm ingested agent, dose, time, co-ingestants (especially MAOIs, other serotonergic drugs).
— Washington Manual of Medical Therapeutics; Rosen's EM, p. 2925
Management
1. Supportive Care (cornerstone)
- Establish IV access, continuous cardiac monitoring, pulse oximetry.
- The vast majority of patients with SSRI poisoning require no specific medical intervention beyond monitoring.
2. Decontamination
- Activated charcoal (50 g oral): Reasonable if the patient presents alert and cooperative within 1 hour of ingestion. Not shown to change outcomes but may reduce absorption.
- Gastric lavage, ipecac, multidose charcoal, and whole-bowel irrigation are not recommended.
— Tintinalli's EM, p. 2199; Rosen's EM, p. 2925
3. Seizures
- First-line: IV benzodiazepines
- Lorazepam 1–4 mg/kg IV push, or
- Diazepam 5–10 mg/kg IV push
- If refractory: Phenobarbital
- Avoid phenytoin (limited efficacy in toxin-induced seizures).
4. Cardiac Dysrhythmias
| Abnormality | Treatment |
|---|---|
| QTc > 500 ms | IV magnesium sulfate 2 g IV |
| Torsades de pointes | Magnesium + overdrive pacing (chemical or electrical) |
| QRS prolongation (rare with sertraline; more with citalopram) | Sodium bicarbonate IV |
| Electrolyte abnormalities | Correct K⁺ and Mg²⁺ to normal levels |
5. Serotonin Syndrome (if features present)
Diagnosis uses the Hunter Criteria (in the setting of a known serotonergic exposure, any one of):
- Spontaneous clonus
- Inducible clonus + agitation or diaphoresis
- Ocular clonus + agitation or diaphoresis
- Tremor + hyperreflexia
- Hypertonia + temp >38°C + ocular or inducible clonus
Management by severity:
| Severity | Treatment |
|---|---|
| Mild | Discontinue the agent; low-dose benzodiazepines (e.g., diazepam 5–10 mg IV) for rigidity |
| Moderate–Severe | Large-dose benzodiazepines (diazepam 10–20 mg IV, titrated in 10 mg aliquots); IV fluids |
| Adjunctive | Cyproheptadine (5-HT₂A antagonist): 12 mg oral single dose for severe/refractory cases. Avoid if anticholinergic toxicity remains on differential — it can worsen anticholinergic syndrome |
| Severe hyperthermia not responding to sedation | Rapid sequence intubation with non-depolarizing neuromuscular blocker (e.g., rocuronium); do NOT use succinylcholine (risk of hyperkalemia from rhabdomyolysis). Antipyretics are NOT effective for serotonin syndrome hyperthermia. |
Symptoms usually resolve within 24 hours with proper treatment, but may persist several days in severe cases.
— Rosen's EM, p. 2925; Washington Manual of Medical Therapeutics, p. 1071
Disposition
| Criteria | Disposition |
|---|---|
| Asymptomatic after 6-hour observation | Can be medically cleared; psychiatric evaluation as needed |
| Tachycardia, altered mental status, cardiac conduction abnormalities, or serotonin syndrome features | Admit with continuous cardiac monitoring |
| Citalopram or escitalopram ingestion (not sertraline, but relevant if misidentified) | Admit regardless of initial appearance due to delayed QT changes |
— Tintinalli's EM, p. 2199; Rosen's EM, p. 2925
Key Points
- Pure sertraline overdose is rarely life-threatening; co-ingestants (especially MAOIs) dramatically increase risk.
- Serotonin syndrome after a single-agent SSRI overdose is uncommon but must be screened for.
- Benzodiazepines are the workhorse for both seizures and serotonin syndrome-related agitation/rigidity.
- The 6-hour observation rule applies to asymptomatic patients — any symptoms mandate admission.
- Avoid succinylcholine for intubation if significant rigidity or rhabdomyolysis is present.
This is a shared conversation. Sign in to Orris to start your own chat.